CON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed

Ariel W. Aday, Nicole E. Rich, Arjmand R. Mufti, Shannan R. Tujios

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalClinical Liver Disease
Volume11
Issue number5
DOIs
Publication statusPublished - May 1 2018

ASJC Scopus subject areas

  • Hepatology

Cite this